Close Menu

This article from the Wall Street Journal examines some of the changes expected as Pfizer unveils its new strategy with its latest chief, Jeffrey Kindler, at the helm. "His plan is likely to involve shedding more jobs and rethinking the way the drug giant develops, makes and markets medicines," according to the story. Analysts are anticipating the new vision to be laid out for the public next Monday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.